EPharmaceuticals™ Releases Analytical Report on New Massachusetts Disclosure Regulations

EPharmaceuticals™ Releases Analytical Report on New Massachusetts Disclosure Regulations



Prepare for the enforcement of a new state law governing marketing and sales activities of pharmaceutical and medical device manufacturers who do business in Massachusetts.



Marblehead, MA (PRWEB) April 27, 2009



ePharmaceuticals™ (http://new. hcpro. com/life-sciences), a division of HCPro, Inc., which is a portfolio company of Halyard Capital, and a leading provider of education and information on healthcare regulatory compliance and management, released its new special report Massachusetts Disclosure Regulations: New Challenges for Pharmaceutical, Medical Device Manufacturers.



The report is available for free download at www. epharmcomply. com/white-papers (http://www. epharmcomply. com/white-papers).



Pharmaceutical and medical device companies must now disclose to the Massachusetts Department of Public Health any payment or economic benefit with a value of at least $50 made for sales or marketing activities. Companies must disclose the type of benefit, the reason for it, and the recipient. Companies are also required to adopt a marketing code of conduct.



Massachusetts Disclosure Regulations: New Challenges for Pharmaceutical, Medical Device Manufacturers (http://blogs. hcpro. com/epharmaceuticals/white-papers/) offers a breakdown of the regulation with commentary and analysis from experts such as Mark Schreiber, Esq. (Edwards Angell Palmer & Dodge, LLP), Mark DuVal, Esq. (DuVal & Associates), and Kate Feola, Esq. (McDermott, Will & Emory LLP).



Download the free special report to learn:

 Why the regulation affects all pharmaceutical and medical device manufacturers, not just those doing business in Massachusetts  When and where the regulations will take effect  What additional regulations apply to pharmaceutical companies  The definition of "sales and marketing activities" and list of specific examples  The impact on innovation of increased time/expense spent on instituting policies and procedures to comply with the new law Visit www. epharmcomply. com/white-papers (http://www. epharmcomply. com/white-papers) throughout the year for frequently published white papers on various important topics.

EPharmaceuticals develops real-world training content that is memorable and effective through several media, including e-learning, handbooks, games, white papers, e-newsletters, multimedia conferences, and consulting. Visit us online at www. epharmcomply. com or call Maureen Croce at 866/464-2776



###